Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30088483HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063793HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS30063794HIVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20008491HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20043606HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TVIS20023643HPVENSG00000164270.19protein_codingHTR4NoNo3360A0A2D3FAF9
Q13639
TCGA Plot Options
Drug Information
GeneHTR4
DrugBank IDDB00320
Drug NameDihydroergotamine
Target IDBE0000084
UniProt IDQ13639
Regulation Typeagonist
PubMed IDs22444161
CitationsDahlof C, Maassen Van Den Brink A: Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Headache. 2012 Apr;52(4):707-14. doi: 10.1111/j.1526-4610.2012.02124.x. Epub 2012 Mar 22.
GroupsApproved; Investigational
Direct ClassificationErgotamines, dihydroergotamines, and derivatives
SMILES[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O
Pathways
PharmGKBPA164743028
ChEMBLCHEMBL1732